AU5633398A - Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical comprising them - Google Patents

Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical comprising them

Info

Publication number
AU5633398A
AU5633398A AU56333/98A AU5633398A AU5633398A AU 5633398 A AU5633398 A AU 5633398A AU 56333/98 A AU56333/98 A AU 56333/98A AU 5633398 A AU5633398 A AU 5633398A AU 5633398 A AU5633398 A AU 5633398A
Authority
AU
Australia
Prior art keywords
sulfonamide
medicament
pharmaceutical
membered ring
ring compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
AU56333/98A
Other versions
AU737461B2 (en
Inventor
Joachim Brendel
Uwe Gerlach
Hans Jochen Lang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hoechst AG
Original Assignee
Hoechst AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst AG filed Critical Hoechst AG
Publication of AU5633398A publication Critical patent/AU5633398A/en
Application granted granted Critical
Publication of AU737461B2 publication Critical patent/AU737461B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
    • C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C311/07—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a ring other than a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • C07D313/02—Seven-membered rings
    • C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D313/08—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/12—One of the condensed rings being a six-membered aromatic ring the other ring being at least seven-membered

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AU56333/98A 1997-02-26 1998-02-25 Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical comprising them Ceased AU737461B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19707656 1997-02-26
DE19707656A DE19707656A1 (en) 1997-02-26 1997-02-26 Sulphonamide-substituted fused 7-ring compounds, processes for their preparation, their use as medicaments or diagnostic agents and pharmaceutical preparations containing them

Publications (2)

Publication Number Publication Date
AU5633398A true AU5633398A (en) 1998-09-03
AU737461B2 AU737461B2 (en) 2001-08-23

Family

ID=7821518

Family Applications (1)

Application Number Title Priority Date Filing Date
AU56333/98A Ceased AU737461B2 (en) 1997-02-26 1998-02-25 Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical comprising them

Country Status (25)

Country Link
EP (1) EP0861836B1 (en)
JP (1) JP4171097B2 (en)
KR (1) KR19980071625A (en)
CN (1) CN1110490C (en)
AR (1) AR011163A1 (en)
AT (1) ATE286039T1 (en)
AU (1) AU737461B2 (en)
BR (1) BR9800207A (en)
CA (1) CA2230349A1 (en)
CZ (1) CZ53998A3 (en)
DE (2) DE19707656A1 (en)
ES (1) ES2234044T3 (en)
HR (1) HRP980098A2 (en)
HU (1) HUP9800395A3 (en)
ID (1) ID19931A (en)
IL (1) IL123454A0 (en)
MX (1) MX9801516A (en)
NO (1) NO980785L (en)
NZ (1) NZ329838A (en)
PL (1) PL325045A1 (en)
RU (1) RU2223264C2 (en)
SK (1) SK283312B6 (en)
TR (1) TR199800301A2 (en)
TW (1) TW452574B (en)
ZA (1) ZA981562B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19858253A1 (en) 1998-12-17 2000-06-21 Aventis Pharma Gmbh Use of KQt1 channel inhibitors for the manufacture of a medicament for the treatment of diseases caused by helminths and ectoparasites
DE19929076A1 (en) * 1999-06-25 2000-12-28 Aventis Pharma Gmbh New indanyl-substituted benzenesulfonamide derivatives, as potassium channel blockers useful as safe antiarrhythmic agents, e.g. for treating atrial fibrillation or flutter
US7119112B2 (en) * 2002-02-28 2006-10-10 Icagen, Inc. Sulfonamides as potassium channel blockers
TW200403058A (en) 2002-04-19 2004-03-01 Bristol Myers Squibb Co Heterocyclo inhibitors of potassium channel function
US7384937B2 (en) 2002-11-06 2008-06-10 Bristol-Myers Squibb Co. Fused heterocyclic compounds and use thereof
US20120309796A1 (en) * 2011-06-06 2012-12-06 Fariborz Firooznia Benzocycloheptene acetic acids
RU2538962C1 (en) * 2013-11-19 2015-01-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Казанский (Приволжский) Федеральный Университет" (ФГАОУ ВПО КФУ) Antifungal compounds based on 3,5,8-trioxabicyclo[5,1,0]octane derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5258510A (en) * 1989-10-20 1993-11-02 Otsuka Pharma Co Ltd Benzoheterocyclic compounds
US5428031A (en) * 1991-12-03 1995-06-27 Merck & Co., Inc. Methods of treating cardiac arrhythmia
GB9225860D0 (en) * 1992-12-11 1993-02-03 Smithkline Beecham Plc Novel treatment

Also Published As

Publication number Publication date
HU9800395D0 (en) 1998-04-28
RU2223264C2 (en) 2004-02-10
DE19707656A1 (en) 1998-08-27
HRP980098A2 (en) 1998-12-31
SK23998A3 (en) 1998-09-09
KR19980071625A (en) 1998-10-26
EP0861836B1 (en) 2004-12-29
HUP9800395A2 (en) 2001-04-28
ID19931A (en) 1998-08-27
PL325045A1 (en) 1998-08-31
DE59812423D1 (en) 2005-02-03
AU737461B2 (en) 2001-08-23
CN1110490C (en) 2003-06-04
AR011163A1 (en) 2000-08-02
TW452574B (en) 2001-09-01
IL123454A0 (en) 1998-09-24
HUP9800395A3 (en) 2002-04-29
BR9800207A (en) 1999-05-18
ES2234044T3 (en) 2005-06-16
NO980785D0 (en) 1998-02-25
EP0861836A1 (en) 1998-09-02
TR199800301A2 (en) 1998-09-21
NZ329838A (en) 1999-07-29
NO980785L (en) 1998-08-27
ZA981562B (en) 1998-08-26
CN1193017A (en) 1998-09-16
SK283312B6 (en) 2003-05-02
JPH10287641A (en) 1998-10-27
ATE286039T1 (en) 2005-01-15
MX9801516A (en) 1998-11-30
CZ53998A3 (en) 1998-09-16
CA2230349A1 (en) 1998-08-26
JP4171097B2 (en) 2008-10-22

Similar Documents

Publication Publication Date Title
AU742593C (en) Disubstituted bicyclic heterocycles, their production and use as medicaments
AU8684798A (en) Multiple dose drug vial adapter
IL147220A0 (en) Indanyl-substituted benzole carbonamide, method for the production of the same, use thereof as a medicament and pharmaceutical preparations containing the same
AU7375598A (en) Stable oral pharmaceutical dosage forms
AU2498597A (en) New benzazepine derivatives, medicaments containing the same and their use to prepare medicaments
HUP9900028A3 (en) Pharmaceutically active quinazoline compounds, their production, use thereof and medicament containing them
AU1850897A (en) Powdered medication inhaler
AU1724301A (en) Hydrogel-driven layered drug dosage form
AU9223098A (en) Dosage form comprising means for changing drug delivery shape
HK1032958A1 (en) Derivatives of acyl-piperazinil-pyrimidins, preparation thereof and application as medicaments.
HUP9900348A3 (en) New oxazolidinone derivatives, preparation and use thereof and medicaments containing these compounds
HUP9903353A3 (en) 7alpha-(methyl-amino-pentyl)-estratrienes, pharmaceutical preparations which contain said 7alpha-(5-methylaminopentyl) -estratrienes and use thereof for production of drugs
BR9811582B1 (en) compounds derived from 4-oxo-3,5-dihydro-4h-pyridazine [4,5-b] indole-1-acetamide, medicament and pharmaceutical composition containing them.
AU5633398A (en) Sulfonamide-substituted fused 7-membered ring compounds, their use as a medicament, and pharmaceutical comprising them
IL126280A (en) Sulfonamide-substituted chromans, processes for their preparation, their use as a medicament and pharmaceutical preparation comprising them
AU5326598A (en) New analogues of camptothecin, their use as medicaments and the pharmaceutical compositions containing them
IL126955A0 (en) Sulfonamide-substituted fused 5-membered ring compounds their use as a medicament and pharmaceutical preparations comprising them
AU1258000A (en) Novel agarofuan derivatives, their preparation, pharmaceutical composition containing them and their use as medicine
ZA989982B (en) Sulfonamide-substituted benzopyran derivatives processes for their preparation their use as a medicament and pharmaceutical preparations comprising them
HRP980527B1 (en) Sulfonamid-substituted chromans, process for their preparation, their use as medicine, and pharmaceutical preparation containing them
AU4362097A (en) Syringe for medicinal purposes
AU5386098A (en) Sulfonamide-substituted compounds, processes for their preparation, their use as a medicament or diagnostic, and medicament comprising them
AU4463797A (en) New heteroaryloxyethylamines, a process for the preparation thereof, their use as medicaments, and pharmaceutical compositions containing them
IL136230A0 (en) An active hedgehog-protein-mutant, a process for its preparation and its use for pharmaceutical purposes
HUP0002403A3 (en) Polyhydroxyalkylpyrazine derivatives, their preparation and medicines containing them

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired